Gilead Gets Buy, Amgen Holds: Biopharma Calls Roil Markets
Wall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
Implement a cashback strategy that targets debt directly, converting rewards into meaningful reductions each month.
22,486 articlesWall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
Nvidia CEO Jensen Huang laid out a striking forecast where AI agents work alongside a much larger human workforce, re...
When a juggernaut like Fortnite cools its engagement, the ripple effect hits the entire company. This piece digs into...
As Oregon voters head into a pivotal primary, a gas-tax hike and related fees put affordability at the forefront. Thi...
A potential 18-day walkout by 45,000 Samsung memory workers could disrupt DRAM and high-bandwidth memory supply, send...
A dramatic one-day move put Relay Therapeutics in the spotlight. After encouraging Phase 2 results for zovegalisib an...
A new flagship SUV from NIO sparked a notable jump in its stock as the ES9 price released below expectations. This ar...
A notable weekly move in the stock market often comes from a mix of policy signals, earnings notes, and sector moment...
The Nasdaq Composite slips as semiconductors lead a broad pullback, challenging confidence in AI-driven growth.
As retirees plan for 2026, three unexpected reasons your Social Security check could shrink surface, from filing timi...
On this stock market today, june, Microsoft shares slipped as AI spending scrutiny intensified amid Xbox restructurin...
A growing number of retirees are using the 62-to-70 Roth conversion window to move sizeable balances into Roth accoun...